At the time of writing, West Pharmaceutical Services, Inc [WST] stock is trading at $230.77, up 2.09%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WST shares have gain 2.31% over the last week, with a monthly amount drifted -28.23%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on February 14, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $250 for it. Previously, Citigroup started tracking the stock with Buy rating on January 08, 2025, and set its price target to $400. On December 13, 2024, Wolfe Research initiated with a Peer Perform rating. UBS upgraded its rating to a Buy and increased its price target to $390 on December 12, 2024. Jefferies upgraded its rating to a Buy and raised its price target to $536 on February 07, 2024. BofA Securities upgraded its rating to Buy for this stock on June 16, 2023, and upped its price target to $405. In a note dated April 11, 2023, Stephens upgraded an Overweight rating on this stock and boosted its target price from $330 to $400.
For the past year, the stock price of West Pharmaceutical Services, Inc fluctuated between $197.01 and $400.88. Currently, Wall Street analysts expect the stock to reach $393 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $230.77 at the most recent close of the market. An investor can expect a potential return of 70.3% based on the average WST price forecast.
Analyzing the WST fundamentals
According to West Pharmaceutical Services, Inc [NYSE:WST], the company’s sales were 2.89B for trailing twelve months, which represents an 2.24% jump. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.18 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 226.99 points at the first support level, and at 223.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 234.45, and for the 2nd resistance point, it is at 238.14.
Ratios To Look Out For
It is important to note that West Pharmaceutical Services, Inc [NYSE:WST] has a current ratio of 2.79. In addition, the Quick Ratio stands at 2.11 and the Cash Ratio stands at 0.88. Considering the valuation of this stock, the price to sales ratio is 5.77, the price to book ratio is 6.22 and price to earnings (TTM) ratio is 34.50.
Transactions by insiders
Recent insider trading involved Witherspoon Charles, VP & Treasurer, that happened on Oct 29 ’24 when 703.0 shares were sold. VP & Treasurer, Witherspoon Charles completed a deal on Aug 19 ’24 to sell 1029.0 shares. Meanwhile, Director Hofmann Thomas W sold 617.0 shares on May 10 ’24.
